The role of intestinal dysbiosis is becoming clearer / Atopic dermatitis and cardiovascular risk / The parents are trustworthy...
ISAD 2016 : 9th Georg Rajka International Symposium on Atopic Dermatitis - May 19 - 21, 2016 - São Paulo (Brazil)T4, 30/12/2015 - 17:59
The 9th edition of the symposium will be held in São Paulo, Brazil, and will be sponsored by the International Society of Atopic Dermatitis (ISAD), the Brazilian Atopic Dermatitis Association (AADA) and the Department of Dermatology of the University of São Paulo Medical School. Registration is by application only.
Knockdown of Filaggrin in a Three-Dimensional Reconstructed Human Epidermis Impairs Keratinocyte DifferentiationT6, 31/07/2015 - 11:08
Valérie Pendaries, Jeremy Malaisse, Laurence Pellerin, Marina Le Lamer, Rachida Nachat, Sanja Kezic, Anne-Marie Schmitt, Carle Paul, Yves Poumay, Guy Serre and Michel Simon
TOPICOP©: A New Scale Evaluating Topical Corticosteroid Phobia among Atopic Dermatitis Outpatients and Their ParentsT6, 31/07/2015 - 11:08
The fear of using topical corticosteroids, usually called topical corticophobia, is a frequent concern for atopic dermatitis patients and/or their parents. Assessing patients’ atopic dermatitis and their parents’ topical corticosteroid phobia is an essential step to improving adherence to treatment. Because topical corticophobia appears to be a complex phenomenon, its evaluation by binary responses (yes/no) is too simplistic. Thus, a scale is needed, which is capable of identifying the subtleties of topical corticosteroid phobia.
The Leuven Itch Scale (LIS). The LIS is an instrument to measure itch in patients experiencing pruritus of different origin. The novelty of the LIS, in contrast with several previously developed instruments, is that it approaches itch as a symptom, and that it consequently measures all aspects of that symptom: frequency, duration, severity, circumstances, treatment, consequences, sensory characteristics, distress and location(s).
The Atopic Dermatitis Foundation propose you to discover an article about fillagrin, a molecule involved in the process of atopic dermatitis.
Therapeutic patient education (TPE) has proven effective in increasing treatment adherence and improving quality of life (QoL) for patients with numerous chronic diseases, especially atopic dermatitis (AD). This study was undertaken to identify worldwide TPE experiences in AD treatment. Experts from 23 hospitals, located in 11 countries, responded to a questionnaire on 10 major items. Patients in TPE programs were mainly children and adolescents with moderate to severe AD or markedly affected QoL...
Atopic dermatitis or eczema is a condition that specialists consider mild, but which gives rise to so many different interpretations, prohibitions, excesses, consultations and conflicting opinions that, in recent years, necessary centers have been set up for listening to patients and providing advice and information in France.
Cow’s milk protein allergies (CMPA) affect 2 to 3% of infants. They appear when weaning or when giving the first bottles of milk. The allergy causes cutaneous, digestive or more rarely respiratory symptoms. Their onset depends on the underlying immunopathological mechanism, which makes a didactic classification and practical exploration of the allergic reactions possible.
*Dr. J. Robert - Pediatrician - Atopic Dermatitis Therapeutic Education Consultation - Lyon Sud Hospital Center - Pavillon Dufour - 69495 Pierre Bénite Cedex